Orchid Chemicals & Pharmaceuticals
Orchid Chemicals inks antibiotics development pact with Europeís Allecra Therapeutics
18 April 2013
Orchid sells API, R&D unit to Hospira for Rs1,113 crore to reduce debt
30 August 2012
Orchid shuts Alathur plant on pollution concerns
12 July 2011
Orchid Chemicals to take over US-based Karalex Pharma
10 June 2010
Orchid in out-licensing deal with Alvogen for oral non-antibiotic for US sales
05 May 2010
Orchid also settles Namenda patent issues with Forest Labs
29 April 2010
Orchid receives tentative FDA approval for Alzheimerís drug Memantine tablet
08 January 2010
Hospira of US buys Orchidís injectables business
16 December 2009
Orchid receives USFDA approval for Zaleplon capsules
18 September 2009
Orchid Chem gets US nod to sell generic antibiotic
16 September 2009
Orchid in pact with Merck & Co to develop novel anti-infective drugs
29 September 2008
Orchid Pharma to make Merck's anti-coagulant drug
14 August 2008
Orchid receives EU approvals for anti-bacterial injections Piperacillin, Tazobactam
04 August 2008
Ranbaxy forces Orchid into an alliance
22 April 2008
Why Ranbaxy fancies Orchid
14 April 2008
Ranbaxy group closer to 15 per cent stake in Orchid
14 April 2008
Ranbaxy's Solrex picks up 1 per cent more in Orchid Chemicals
11 April 2008
Orchid Chemicals announces Japanese subsidiary
10 April 2008
Orchid Chemicals stock surges as Ranbaxy group hikes stake
08 April 2008
US FDA approval Orchid's ANDA for Cefpodoxime Proxetil
17 November 2007
Orchid Chem to launch three new products in the US
18 July 2007
Orchid enters Canadian market with two generic formulations
10 April 2007
Orchid to help Swedish drug major in drug research
30 October 2006
Orchid's formulation and API facilities approved by UK MHRA
21 September 2006
Expect Tazobactum approval by June 07: Orchid Chem
16 August 2006
Orchid to acquire 100 per cent in US drug discovery unit Bexel
01 August 2006
Orchid Chemicals hosts presidential visit at its formulations complex
31 July 2006
Higher investments, rural affluence results in exponential corporate growth
23 March 2006
Orchid Chemicals hosts presidential visit at its formulations complex
02 December 2005
Orchid Chemicals' fire victims were insured: K Raghavendra Rao
08 November 2005
Orchid Chemicals strengthens finances with GDR and FCCB issue
31 October 2005
1: 2 bonus from Orchid Chemicals
18 July 2005
Orchid in deal with Stada for generic drug products
17 March 2005
Orchid registers turnover of Rs173.86 crore for Q1 FY 2004-05
31 July 2004
Orchid in tie up with Par Pharmaceuticals Inc. to market oral cephalosporin in the US
28 May 2004
Orchid's US discovery JV successful
22 May 2004
Orchid files ANDA for Cefazolin finished dosage form
15 May 2004
Orchid's net profit rises 59 per cent on Rs 713 crore turnover during '03 -'04
26 April 2004
Orchid Pharma soon to file ANDA from its new plant
13 April 2004
Orchid Pharma soon to file ANDA from its new plant
02 April 2004
Orchid granted Certificate of Suitability for Cefadroxil Monohydrate
30 March 2004
Orchid to raise USD 75 million through FCCBs
20 March 2004
One more CoS for Orchid Chemicals
19 February 2004
Dr C B Rao-a man for all seasons
04 February 2004
Orchid posts good Q3 performance
16 January 2004
Orchid Aurangabad facility bags ISO 14001, OHSAS 18001
31 December 2003
European approval for Orchid Chemical's drug
18 December 2003
USFDA approval for Orchid
05 December 2003
IFC sells part of stake in Orchid Chemicals
20 November 2003
Orchid income at Rs 162 crore
04 November 2003
Orchid Pharma's API facilities inspected by EDQM, MHRA UK
06 October 2003
Orchid JV manufacturing facility in China commissioned
20 September 2003
Orchid's API and formulation facilities receive TGA approval
01 August 2003
Orchid Chem Q1 profits up
25 July 2003
Orchid's US drug discovery JV progresses well on BLX 1002
01 July 2003
Orchid, Apotex in exclusive pact to sell injectable antibiotics in US
03 June 2003
Orchid registers Rs 541-crore turnover; posts 27% growth
02 May 2003
Orchid Pharma's Cephalexin approved by USFDA, EDQM
24 February 2003
Orchid Chemicals net down to Rs 9.51 cr; turnover at 346.45 cr
28 January 2003
Orchid Chemicals acquires Mano Pharma, Sali Healthcare
17 December 2002
Orchid Chemicals procures USFDA approval for Cephalexin
11 November 2002
Orchid Chemicals in equal JV with NCPC
20 July 2002
Orchid to invest $10m in US research JV
03 July 2002
Orchid Chemicals to go slow on nutraceuticals
31 May 2002
Orchid focuses on formulations market
27 March 2002
Pharma sector fared well in 2001
28 December 2001
Orchid Pharma starts work on new plant
21 November 2001
Orchid Chemicals: gap between promise and performance
02 August 2001
Orchid Chemicals inks co-marketing agreements and starts health portal
29 June 2001
Deployment of funds
20 February 2001
A big shot in the arm
10 February 2000
Formulating profits
10 February 2000
K. Raghavendra Rao: the man outside office
10 February 2000
The steps to self-fulfillment
10 February 2000
About Orchid
04 January 2000
Financial Highlights
04 January 2000
Orchid acquires Ajanta''s bulk drug unit
04 January 2000
 search domain-b
  go